Davis's Drug Guide
sofosbuvir
General
Genetic Implications:
Pronunciation:
soe-fos-bue-vir
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Sovaldi
Ther. Class.
Pharm. Class.
polymerase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Sofosbuvir." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110123/all/sofosbuvir.
Vallerand AHA, Sanoski CAC. Sofosbuvir. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110123/all/sofosbuvir. Accessed June 26, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Sofosbuvir. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110123/all/sofosbuvir
Vallerand AHA, Sanoski CAC. Sofosbuvir [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 26]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110123/all/sofosbuvir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - sofosbuvir
ID - 110123
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110123/all/sofosbuvir
PB - F.A. Davis Company
ET - 20
DB - The Washington Manual
DP - Unbound Medicine
ER -
